Kelly Paul Edward

COO Kelly Paul Edward buys 90,000 RLMD shares at $2.20; holdings rise to 502,295 shares (+21.8%); 3 other insiders also bought within 14 days

Kelly Paul Edward, COO, purchased 90,000 shares at $2.20 on 2025-11-05, increasing his holdings by 21.8% to 502,295 shares total. The transaction occurred within a broader cluster pattern: 3 other insiders also bought within the past 14 days, suggesting coordinated insider confidence at this price point. His same-ticker trade history is mixed—a May 2025 buy yielded +62.7% in 30 days and +41.1% in 90 days, while a September 2024 buy declined -82.3% by the 90-day mark—underscoring the volatility and unpredictability of timing outcomes in this stock. RLMD's fundamentals remain challenged: the company posted a $-9.9M net loss most recently and showed -35.4% annual revenue decline, despite the stock's recent 30-day surge of +31.2% from depressed levels. The cluster buy pattern warrants investor attention as a potential signal of management's view of intrinsic value, though the company's unprofitable status and negative revenue trajectory raise material questions about capital allocation discipline in a highly volatile biotech context.

COO Kelly Paul Edward buys 200,000 shares of RLMD at $0.43; stock now $0.60, but company posted -$17.6M net income with -35.4% revenue decline.

Kelly Paul Edward, Chief Operating Officer, purchased 200,000 shares (200.0K shares) at $0.43 on 2025-05-16, increasing his holdings by 94.2% to 412.3K shares. The purchase totaled $86.1K. However, the company faces significant financial headwinds: latest quarterly revenue stood at $682.00, full-year net income was -$17.6M, and annual revenue has declined 35.4% year-over-year. His prior buy at RLMD on 2024-09-09 returned +31.3% over 30 days but -82.3% over 90 days, establishing a pattern of initial gains followed by substantial losses at this ticker. The stock has recovered 107% over the past 30 days from depressed levels but remains 86.2% below its 52-week high of $4.36, and his cross-ticker track record shows a 0% win rate on 90-day outcomes despite one prior buy. The concurrent cluster of 3 other insider buys within 14 days warrants consideration as potential coordinated action, but set against deteriorating fundamentals and a company burning capital, this transaction signals distress rather than fundamental conviction.

Director Kelly Paul Edward buys 25,000 shares of RLMD at $2.59; 3 other insiders also bought within 14 days.

Kelly Paul Edward, a director, purchased 25,000 shares at $2.59 on 2024-09-09, increasing his holdings by 13.3% to 212,295 shares post-transaction. This purchase occurs within a cluster pattern: 3 other insiders also bought within the past 14 days. The timing aligns with the stock trading 55.6% below its 52-week high of $6.80, following a -35.4% annual revenue decline and full-year net loss of $-17.8M. The coordinated multi-insider buying activity during a depressed valuation period in an unprofitable company warrants close attention to whether this reflects material non-public information or a shift in operational outlook.